Biochemical Assessment of Diabetic Nephropathy in Newly Diagnosed Diabetes Mellitus Patients in Pakistan
European Journal of Clinical Pharmacy · 20.12.2025 · 7 (1) · 6140-6144
DOI: 10.61336/ejcp/26-01-280 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 20.12.2025. Verfasst von Imtiaz Ali.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic nephropathy is a very severe and one of the most ancient microvascular sequelae of diabetes mellitus, and usually it starts silently, before the clinical manifestation. The identification of early biochemistry in patients with newly diagnosed diabetes is crucial to prevent the development of chronic renal disease and end stage renal failure, especially in developing countries where the incidence of diabetes is on the increase.
Objective
To evaluate early biochemical indicators of diabetic nephropathy among newly diagnosed diabetes mellitus patients. Methodology: This analytical study based on cross-section was carried out in January 2024 January 2025 at Rai foundation teaching hospital Sargodha. Those patients who were newly diagnosed with diabetes mellitus were included in the study by use of non-probability consecutive sampling (n=72). They were demographic information, glycemic indices, renal function analysis, and urinary albumin-creatinine ratio. Analysis was done on serum creatinine, estimated glomerular filtration rate (eGFR), blood urea, HbA1c, fasting plasma glucose and urine microalbumin. Data analysis was done by use of SPSS 26. Independent t -test, Pearson correlation test, and Chi-square test were used with p 0.05 being treated as significant.
Results
Microalbuminuria was detected in 33.3% patients at diagnosis. Patients with HbA1c ≥ 8% showed significantly higher urinary albumin-creatinine ratio and lower eGFR (p < 0.001). Serum creatinine and blood urea demonstrated a moderate positive correlation with HbA1c levels.
Conclusion
Biochemical evidence of early nephropathy is present in a considerable proportion of newly diagnosed diabetes patients. Screening using urine albumin-creatinine ratio and eGFR at diagnosis can facilitate early intervention and prevent long-term renal complications
Zitieren
APA
Ali, I. (2025). Biochemical Assessment of Diabetic Nephropathy in Newly Diagnosed Diabetes Mellitus Patients in Pakistan. European Journal of Clinical Pharmacy, 7(1), 6140-6144. https://doi.org/10.61336/ejcp/26-01-280
Vancouver
Ali I. Biochemical Assessment of Diabetic Nephropathy in Newly Diagnosed Diabetes Mellitus Patients in Pakistan. European Journal of Clinical Pharmacy. 2025;7(1):6140-6144. doi:10.61336/ejcp/26-01-280
BibTeX
@article{Ali2025,
author = {Ali, Imtiaz},
title = {Biochemical Assessment of Diabetic Nephropathy in Newly Diagnosed Diabetes Mellitus Patients in Pakistan},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {6140--6144},
doi = {10.61336/ejcp/26-01-280}
}
EUVIMED